List Of Hormonal Cytostatic Antineoplastic Agents
This is a list of dual hormonal antineoplastic agent, hormonal and cytostatic antineoplastic agents. Marketed Estrogen-based * Estramustine phosphate (Emcyt, Estracyt; Leo 299, NSC-89199, Ro 21-8837/001; estradiol 3-[bis(2-chloroethyl)carbamate] dihydrogen phosphate) Corticosteroid-based * Prednimustine (Mostarina, Sterecyst; chlorambucil prednisolone ester; prednisolone 21-(4-(4-(bis(2-chloroethyl)amino)phenyl)butanoate)) Never marketed Estrogen-based * Alestramustine (estradiol 3-(bis(2-chloroethyl)carbamate) 17β-(L-alaninate)) * Atrimustine (bestrabucil, busramustine; KM-2210; estradiol 3-benzoate 17β-((4-(4-(bis(2-chloroethyl)amino)phenyl)-1-oxobutoxy)acetate) * Cytestrol acetate (1α-hydroxyethinylestradiol 3-(bis(2-chloroethyl)carbamate) 11α,17β-diacetate) * Estradiol mustard (NSC-112259; chlorphenacyl estradiol diester; estradiol 3,17β-bis(4-(bis(2-chloroethyl)amino)phenyl)acetate) * Estramustine (Leo 275, Ro 21–8837; estradiol 3-(bis(2-chloroethyl)carbamate) est ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Estramustine Phosphate
Estramustine phosphate (EMP), also known as estradiol normustine phosphate and sold under the brand names Emcyt and Estracyt, is a dual estrogen and chemotherapy medication which is used in the treatment of prostate cancer in men. It is taken multiple times a day by mouth or by injection into a vein. Side effects of EMP include nausea, vomiting, gynecomastia, feminization, demasculinization, sexual dysfunction, blood clots, and cardiovascular complications. EMP is a dual cytostatic and hence chemotherapeutic agent and a hormonal anticancer agent of the estrogen type. It is a prodrug of estramustine and estromustine in terms of its cytostatic effects and a prodrug of estradiol in relation to its estrogenic effects. EMP has strong estrogenic effects at typical clinical dosages, and consequently has marked antigonadotropic and functional antiandrogenic effects. EMP was introduced for medical use in the early 1970s. It is available in the United States, Canada, the United K ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Estromustine
Estromustine (developmental code name Leo 271 f), also known as estrone 17β-3-N-bis(2-chloroethyl)carbamate or estrone–cytostatic complex, is a major active metabolite of the cytostatic antineoplastic agent and estrogen estramustine phosphate, a medication used in the treatment of prostate cancer. See also * List of hormonal cytostatic antineoplastic agents This is a list of dual hormonal antineoplastic agent, hormonal and cytostatic antineoplastic agents. Marketed Estrogen-based * Estramustine phosphate (Emcyt, Estracyt; Leo 299, NSC-89199, Ro 21-8837/001; estradiol 3- List of estrogen esters § Estradiol esters References Abandoned drugs">List of estrogen esters#Estradiol esters">List of estrogen esters § Estradiol esters References Abandoned drugs Antiandrogens Antigonadotropins Antineoplastic drugs Carbamates Chloroethyl compounds Estradiol esters Estranes Estrogens Human drug metabolites Ketones Mitotic inhibitors Nitrogen mustards Organochlorides ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Antineoplastic Drugs
Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents or alkylating agents) as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent (which almost always involves combinations of drugs) or it may aim to prolong life or to reduce symptoms ( palliative chemotherapy). Chemotherapy is one of the major categories of the medical discipline specifically devoted to pharmacotherapy for cancer, which is called ''medical oncology''. The term ''chemotherapy'' has come to connote non-specific usage of intracellular poisons to inhibit mitosis (cell division) or induce DNA damage, which is why inhibition of DNA repair can augment chemotherapy. The connotation of the word chemotherapy excludes more selective agents that block extracellular signals ( signal transduction). The development of therapies with specific molecular or genetic targets, ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Cortifen
Cortifen, also known as cortiphen or kortifen, as well as fencoron, is a synthetic glucocorticoid corticosteroid and cytostatic antineoplastic agent which was developed in Russia for potential treatment of tumors. It is a hydrophobic chlor phenacyl nitrogen mustard ester of 11-deoxycortisol (cortodoxone). See also * List of hormonal cytostatic antineoplastic agents * List of corticosteroid esters This is a list of corticosteroid esters, including esters of steroidal glucocorticoids and mineralocorticoids. Esters of natural corticosteroids Desoxycortone esters * Desoxycortone acetate (deoxycortone acetate; desoxycorticosterone aceta ... References Acetate esters Tertiary alcohols Amines Corticosteroid esters Glucocorticoids Ketones Mineralocorticoids Nitrogen mustards Organochlorides Prodrugs Russian drugs Chloroethyl compounds {{Antineoplastic-drug-stub ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Testifenon
Testifenon, also known as testiphenon, testiphenone, chlorphenacyl dihydrotestosterone ester, or dihydrotestosterone 17β-(4-(bis(2-chloroethyl)amino)phenyl)acetate, is a synthetic anabolic–androgenic steroid (AAS) and a cytostatic antineoplastic agent (i.e., chemotherapeutic) that was never marketed. It is an androgen ester – specifically, a chlor phenacyl nitrogen mustard ester of dihydrotestosterone (DHT) – and acts as a prodrug of these two components in the body. The drug was developed in Russia as a tissue-selective cytostatic drug for the treatment of various cancers occurring in androgen receptor-expressing tissues that would have reduced side effects and toxicity relative to other chemotherapy drugs. See also * List of hormonal cytostatic antineoplastic agents This is a list of dual hormonal antineoplastic agent, hormonal and cytostatic antineoplastic agents. Marketed Estrogen-based * Estramustine phosphate (Emcyt, Estracyt; Leo 299, NSC-89199, Ro 21-8837/001; ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Sturamustine
Sturamustine, also known as dehydroepiandrosterone (DHEA) 17β-''N''-(2-chloroethyl)-''N''-nitrosourea, is a synthetic androstane steroid and a C17β nitrosourea conjugate of dehydroepiandrosterone (DHEA) which was developed as a cytostatic antineoplastic agent (i.e., a chemotherapy drug) for the treatment of hormone-dependent tumors but was never marketed. It was synthesized in 1982. See also * List of hormonal cytostatic antineoplastic agents This is a list of dual hormonal antineoplastic agent, hormonal and cytostatic antineoplastic agents. Marketed Estrogen-based * Estramustine phosphate (Emcyt, Estracyt; Leo 299, NSC-89199, Ro 21-8837/001; estradiol 3- is(2-chloroethyl)carbamate ... * List of androgen esters References Abandoned drugs Anabolic–androgenic steroids Androstanes Antineoplastic drugs Experimental cancer drugs Nitrosoureas Organochlorides Prodrugs Steroid esters Chloroethyl compounds {{Steroid-stub ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
LS-1727
LS-1727 (also known as nandrolone 17β-''N''-(2-chloroethyl)-''N''-nitrosocarbamate) is a synthetic, injected anabolic–androgenic steroid (AAS) and a nitrosocarbamate ester of nandrolone (19-nortestosterone) which was developed as a cytostatic antineoplastic agent but was never marketed. See also * List of hormonal cytostatic antineoplastic agents This is a list of dual hormonal antineoplastic agent, hormonal and cytostatic antineoplastic agents. Marketed Estrogen-based * Estramustine phosphate (Emcyt, Estracyt; Leo 299, NSC-89199, Ro 21-8837/001; estradiol 3- List of androgen esters § Nandrolone esters References Abandoned drugs">List of androgen esters#Nandrolone esters">List of androgen esters § Nandrolone esters References Abandoned drugs Androgens and anabolic steroids Antineoplastic drugs Estranes Hormonal antineoplastic drugs Nandrolone esters Nitrogen mustards Organochlorides Prodrugs Progestogens Chloroethyl compounds Nitrosocarbamates { ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Phenestrol
Phenestrol, or fenestrol, also known as hexestrol bis -[bis(2-chloroethyl)aminohenylacetate, is a synthetic compound">synthetic, nonsteroidal estrogen and cytostatic antineoplastic agent (i.e., chemotherapy drug) and a chlorine, chlorphenyl group, phenacyl group, acyl nitrogen mustard ester of hexestrol which was developed in the early 1960s for the treatment of hormone-dependent tumors but was never marketed. See also * List of hormonal cytostatic antineoplastic agents This is a list of dual hormonal antineoplastic agent, hormonal and cytostatic antineoplastic agents. Marketed Estrogen-based * Estramustine phosphate (Emcyt, Estracyt; Leo 299, NSC-89199, Ro 21-8837/001; estradiol 3- is(2-chloroethyl)carbamate ... * List of estrogen esters References Abandoned drugs Antineoplastic drugs Carboxylate esters Estrogen esters Hormonal antineoplastic drugs Nitrogen mustards Phenols Synthetic estrogens Chloroethyl compounds {{Genito-urinary-drug-stub ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
ICI-85966
ICI-85966 (former tentative brand name Stilbostat), also known as diethylstilbestrol (DES) bis(di(2-chloroethyl)carbamate), is a synthetic compound, synthetic, nonsteroidal estrogen (medication), estrogen and cytostatic antineoplastic agent of the stilbestrol group and a nitrogen mustard ester of diethylstilbestrol (DES) which was developed for the treatment of breast cancer and prostate cancer but was never marketed (possibly due to the toxicity of DES). See also * List of hormonal cytostatic antineoplastic agents * List of estrogen esters References Abandoned drugs Antineoplastic drugs Estrogen esters Hormonal antineoplastic drugs Carbamates Phenols Synthetic estrogens Chloroethyl compounds {{Genito-urinary-drug-stub ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Estramustine
Estramustine (, , ) is an estrogen and cytostatic antineoplastic agent which was never marketed. It is an estrogen ester – specifically, the C3 normustine ester of estradiol – and acts in part as a prodrug of estradiol in the body. Estramustine phosphate, the C17β phosphate ester of estramustine and a prodrug of estramustine, estromustine, estradiol, and estrone, is marketed and used in the treatment of prostate cancer. See also * List of hormonal cytostatic antineoplastic agents This is a list of dual hormonal and cytostatic antineoplastic agents. Marketed Estrogen-based * Estramustine phosphate (Emcyt, Estracyt; Leo 299, NSC-89199, Ro 21-8837/001; estradiol 3- is(2-chloroethyl)carbamatedihydrogen phosphate) Cortico ... * List of estrogen esters § Estradiol esters References Abandoned drugs Antiandrogens Antigonadotropins Antineoplastic drugs Carbamates Chloroethyl compounds Secondary alcohols Estradiol esters Estranes Estrogens Hormonal antineop ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Hormonal Antineoplastic Agent
Hormonal therapy in oncology is hormone therapy for cancer and is one of the major modalities of medical oncology (pharmacotherapy for cancer), others being cytotoxic chemotherapy and targeted therapy (biotherapeutics). It involves the manipulation of the endocrine system through exogenous or external administration of specific hormones, particularly steroid hormones, or drugs which inhibit the production or activity of such hormones (hormone antagonists). Because steroid hormones are powerful drivers of gene expression in certain cancer cells, changing the levels or activity of certain hormones can cause certain cancers to cease growing, or even undergo cell death. Surgical removal of endocrine organs, such as orchiectomy and oophorectomy can also be employed as a form of hormonal therapy. Hormonal therapy is used for several types of cancers derived from hormonally responsive tissues, including the breast, prostate, endometrium, and adrenal cortex. Hormonal therapy may also be ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Estradiol Mustard
Estradiol mustard, also known as chlorphenacyl estradiol diester, as well as estradiol 3,17β-bis(4-(bis(2-chloroethyl)amino)phenyl)acetate, is a synthetic, steroidal estrogen and cytostatic antineoplastic agent and a chlor phenacyl nitrogen mustard-coupled estrogen ester that was never marketed. It is selectively distributed into estrogen receptor (ER)-positive tissues such as ER-expressing tumors like those seen in breast and prostate cancers. For this reason, estradiol mustard and other cytostatic-linked estrogens like estramustine phosphate have reduced toxicity relative to non-linked nitrogen mustard cytostatic antineoplastic agents. However, they may stimulate breast tumor growth due to their inherent estrogenic activity and are said to be devoid of major therapeutic efficacy in breast cancer, although estramustine phosphate has been approved for and is used (almost exclusively) in the treatment of prostate cancer. See also * List of hormonal cytostatic antineoplastic ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |